Previous Nav
Net Change on 05-09-2025
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Ltd.
Apollo Hospitals Enterprise Ltd.
Treps
Cipla Ltd.
Torrent Pharmaceuticals Ltd.
Fortis Healthcare Ltd.
Divi's Laboratories Ltd.
Piramal Pharma Ltd.
Alkem Laboratories Ltd.
Neuland Laboratories Ltd.
Aurobindo Pharma Ltd.
Abbott India Ltd.
IPCA Laboratories Ltd.
Metropolis Healthcare Ltd.
Gland Pharma Ltd.
Artemis Medicare Services Ltd.
Glenmark Pharmaceuticals Ltd.
Onesource Specialty Pharma Ltd.
Navin Fluorine International Ltd.
Dr Agarwal's Health Care Ltd.
Mankind Pharma Ltd.
Concord Biotech Ltd.
Global Health Ltd.
Max Healthcare Institute Ltd.
Syngene International Ltd.
JB Chemicals & Pharmaceuticals Ltd.
Anthem Biosciences Ltd.
Vinati Organics Ltd.
Acutaas Chemicals Ltd.
Linde India Ltd.
Net Receivables / (Payables)
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Chemicals
Miscellaneous
Business Support
Industrial Gases & Fuels
Cash
Equity
LIC MF Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to LIC Mutual Fund. It was launched on 28-Feb-2019 and currently has an AUM of ₹88.29 crore. LIC MF Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.
The NAV of LIC MF Healthcare Fund ended down ₹-0.1(-0.32%)yesterday to ₹32.1533.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and
The LIC MF Healthcare Fund is managed by Karan Doshi .
4th Floor, Industrial Assurance Building, Opp. Churchgate Station, Mumbai - 400 020